McLaughlin JP, Chavkin C (2001) Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy. Mol Pharmacol 59, 1360-8 11353794

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

Y106-p - MOR-1 (rat) ▲

Modsite: MKtAtNIyIFNLALA SwissProt Entrez-Gene Orthologous residues MOR‑1 (human): Y108‑p, MOR‑1 iso5 (human): Y108‑p, MOR‑1 (mouse): Y106‑p, MOR‑1 (rat): Y106‑p Characterization Methods used to characterize site in vivo:  mutation of modification site Relevant cell lines - cell types - tissues:  oocyte [CPEB (mouse)] Cellular systems studied:  primary cells Species studied:  frog Downstream Regulation Effect of modification (function):  activity, inhibited

Y166-p - MOR-1 (rat) ▲

Modsite: CTMSVDRyIAVCHPV SwissProt Entrez-Gene Orthologous residues MOR‑1 (human): Y168‑p, MOR‑1 iso5 (human): Y168‑p, MOR‑1 (mouse): Y166‑p, MOR‑1 (rat): Y166‑p Characterization Methods used to characterize site in vivo:  mutation of modification site Relevant cell lines - cell types - tissues:  oocyte [CPEB (mouse)] Cellular systems studied:  primary cells Species studied:  frog Downstream Regulation Effect of modification (function):  activity, inhibited